All data are based on the daily closing price as of December 24, 2024
l

L&C Bio

290650.KQ
15.42 USD
0.15
+0.98%

Overview

Last close
15.42 usd
Market cap
349.79M usd
52 week high
31.98 usd
52 week low
10.89 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
7.0848
Price/Book Value
3.5017
Enterprise Value
382.83M usd
EV/Revenue
7.9767
EV/EBITDA
7.9122

Key financials

Revenue TTM
49.37M usd
Gross Profit TTM
18.50M usd
EBITDA TTM
8.87M usd
Earnings per Share
N/A usd
Dividend
0.07 usd
Total assets
257.96B usd
Net debt
N/A usd

About

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    290650.KQ
  • Exchange
    KQ
  • Isin
    KR7290650001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Mr. Chul Lee Whan
  • Headquarter
    Seongnam-si
  • Web site
    https://www.lncbio.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top